Search Results

There are 9236 results for: content related to: KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer

  1. Tumor Heterogeneity Revealed by KRAS, BRAF, and PIK3CA Pyrosequencing: KRAS and PIK3CA Intratumor Mutation Profile Differences and Their Therapeutic Implications

    Human Mutation

    Volume 35, Issue 3, March 2014, Pages: 329–340, Vivian Kosmidou, Eftychia Oikonomou, Margarita Vlassi, Spyros Avlonitis, Anastasia Katseli, Iraklis Tsipras, Despina Mourtzoukou, Georgios Kontogeorgos, Georgios Zografos and Alexander Pintzas

    Article first published online : 15 JAN 2014, DOI: 10.1002/humu.22496

  2. You have full text access to this OnlineOpen article
    Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma

    Histopathology

    Volume 58, Issue 5, April 2011, Pages: 679–692, Karoliina Stefanius, Laura Ylitalo, Anne Tuomisto, Rami Kuivila, Tiina Kantola, Päivi Sirniö, Tuomo J Karttunen and Markus J Mäkinen

    Article first published online : 4 APR 2011, DOI: 10.1111/j.1365-2559.2011.03821.x

  3. Mitochondrial DNA mutations in respiratory complex-I in never-smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation

    Journal of Cellular Physiology

    Volume 227, Issue 6, June 2012, Pages: 2451–2460, Santanu Dasgupta, Ethan Soudry, Nitai Mukhopadhyay, Chunbo Shao, John Yee, Stephan Lam, Wan Lam, Wei Zhang, Adi F Gazdar, Paul B Fisher and David Sidransky

    Article first published online : 24 FEB 2012, DOI: 10.1002/jcp.22980

  4. You have full text access to this OnlineOpen article
    Mutational analysis of cytocentrifugation supernatant fluid from pancreatic solid mass lesions

    Diagnostic Cytopathology

    Volume 42, Issue 8, August 2014, Pages: 719–725, Sydney D. Finkelstein, Marluce Bibbo, Thomas E. Kowalski, David E. Loren, Ali A. Siddiqui, Charalambos Solomides and Eric Ellsworth

    Article first published online : 22 NOV 2013, DOI: 10.1002/dc.23048

  5. You have full text access to this OnlineOpen article
    A systematic review of treatment guidelines for metastatic colorectal cancer

    Colorectal Disease

    Volume 14, Issue 2, February 2012, Pages: e31–e47, M. S. Edwards, S. D. Chadda, Z. Zhao, B. L. Barber and D. P. Sykes

    Article first published online : 10 JAN 2012, DOI: 10.1111/j.1463-1318.2011.02765.x

  6. You have full text access to this OnlineOpen article
    Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

    EMBO Molecular Medicine

    Volume 2, Issue 5, May 2010, Pages: 146–158, Dora Dias-Santagata, Sara Akhavanfard, Serena S. David, Kathy Vernovsky, Georgiana Kuhlmann, Susan L. Boisvert, Hannah Stubbs, Ultan McDermott, Jeffrey Settleman, Eunice L. Kwak, Jeffrey W. Clark, Steven J. Isakoff, Lecia V. Sequist, Jeffrey A. Engelman, Thomas J. Lynch, Daniel A. Haber, David N. Louis, Leif W. Ellisen, Darrell R. Borger and A. John Iafrate

    Article first published online : 29 APR 2010, DOI: 10.1002/emmm.201000070

  7. The status of EGFR-associated genes could predict the outcome and tumor response of chemo-refractory metastatic colorectal patients using cetuximab and chemotherapy

    Journal of Surgical Oncology

    Volume 104, Issue 6, 1 November 2011, Pages: 661–666, Jen-Kou Lin, An-Jen Lin, Chun-Chi Lin, Yuan-Tzu Lan, Shung-Haur Yang, Anna Fen-Yau Li and Shih-Ching Chang

    Article first published online : 13 JUN 2011, DOI: 10.1002/jso.21993

  8. You have free access to this content
    KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue

    International Journal of Cancer

    Volume 133, Issue 1, July 2013, Pages: 130–141, Bianca Mostert, Yuqiu Jiang, Anieta M. Sieuwerts, Haiying Wang, Joan Bolt-de Vries, Katharina Biermann, Jaco Kraan, Zarina Lalmahomed, Anne van Galen, Vanja de Weerd, Petra van der Spoel, Raquel Ramírez-Moreno, Cornelis Verhoef, Jan N.M. IJzermans, Yixin Wang, Jan-Willem Gratama, John A. Foekens, Stefan Sleijfer and John W.M. Martens

    Article first published online : 9 FEB 2013, DOI: 10.1002/ijc.27987

  9. BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild-type RAS

    American Journal of Hematology

    Volume 89, Issue 5, May 2014, Pages: 499–504, Liping Zhang, Rajesh R. Singh, Keyur P. Patel, Francesco Stingo, Mark Routbort, M. James You, Roberto N. Miranda, Guillermo Garcia-Manero, Hagop M. Kantarjian, L. Jeffrey Medeiros, Rajyalakshmi Luthra and Joseph D. Khoury

    Article first published online : 10 FEB 2014, DOI: 10.1002/ajh.23652

  10. KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma

    Cytopathology

    Volume 22, Issue 6, December 2011, Pages: 358–364, N. K. B. Pang, M. E. Nga, S. Y. Chin, T. M. Ismail, G. L. Lim, R. Soong and M. Salto-Tellez

    Article first published online : 4 OCT 2010, DOI: 10.1111/j.1365-2303.2010.00812.x

  11. You have free access to this content
    Individualized therapy for metastatic colorectal cancer

    Journal of Internal Medicine

    Volume 274, Issue 1, July 2013, Pages: 1–24, A. Silvestri, E. Pin, A. Huijbers, R. Pellicani, E. M. Parasido, M. Pierobon, E. Petricoin, L. Liotta and C. Belluco

    Article first published online : 12 APR 2013, DOI: 10.1111/joim.12070

  12. You have free access to this content
    Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma

    Cancer

    Volume 118, Issue 24, 15 December 2012, Pages: 6243–6252, Jeffrey S. Rose, Derek S. Serna, Ludmila Katherine Martin, Xiaobai Li, Lynn M. Weatherby, Sherif Abdel-Misih, Weiqiang Zhao and Tanios Bekaii-Saab

    Article first published online : 6 JUN 2012, DOI: 10.1002/cncr.27666

  13. You have free access to this content
    Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications

    Cancer

    Volume 113, Issue 11, 1 December 2008, Pages: 3199–3208, Chun-Chieh Wu, Hui-Yu Hsu, Hui-Ping Liu, John Wen-Cheng Chang, Ya-Ting Chen, Wen-Yu Hsieh, Jia-Juan Hsieh, Meng-Shu Hsieh, Yi-Rong Chen and Shiu-Feng Huang

    Article first published online : 17 OCT 2008, DOI: 10.1002/cncr.23925

  14. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas

    The Journal of Pathology

    Volume 212, Issue 3, July 2007, Pages: 287–294, H Sakamoto, J Shimizu, Y Horio, R Ueda, T Takahashi, T Mitsudomi and Y Yatabe

    Article first published online : 29 MAY 2007, DOI: 10.1002/path.2165

  15. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy

    Journal of Surgical Oncology

    Volume 106, Issue 2, 1 August 2012, Pages: 123–129, Hao-Wei Teng, Yu-Chung Huang, Jen-Kou Lin, Wei-Shone Chen, Tzu-Chen Lin, Jeng-Kai Jiang, Chueh-Chuan Yen, Anna Fen-Yau Li, Hsei-Wei Wang, Shih-Ching Chang, Yuan-Tzu Lan, Chun-Chi Lin, Huann-Sheng Wang and Shung-Haur Yang

    Article first published online : 13 FEB 2012, DOI: 10.1002/jso.23063

  16. Anti-EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 128–155, Dr Benoit You and Dr Eric X. Chen

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010395940

  17. You have free access to this content
    KRAS and BRAF mutations in anal carcinoma

    APMIS

    Volume 123, Issue 1, January 2015, Pages: 53–59, Eva Serup-Hansen, Dorte Linnemann, Estrid Høgdall, Poul Flemming Geertsen and Hanne Havsteen

    Article first published online : 22 SEP 2014, DOI: 10.1111/apm.12306

  18. Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: A retrospective review of 50 cases

    Diagnostic Cytopathology

    Volume 41, Issue 1, January 2013, Pages: 15–21, Jonathan D. Marotti, Mary C. Schwab, Nancy J. McNulty, James R. Rigas, Peter A. DeLong, Vincent A. Memoli, Gregory J. Tsongalis and Vijayalakshmi Padmanabhan

    Article first published online : 16 JUN 2011, DOI: 10.1002/dc.21749

  19. You have free access to this content
    Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer

    Cancer

    Volume 118, Issue 6, 15 March 2012, Pages: 1523–1532, Fotios Loupakis, Chiara Cremolini, Lisa Salvatore, Marta Schirripa, Sara Lonardi, Vanja Vaccaro, Federica Cuppone, Diana Giannarelli, Vittorina Zagonel, Francesco Cognetti, Giampaolo Tortora, Alfredo Falcone and Emilio Bria

    Article first published online : 25 AUG 2011, DOI: 10.1002/cncr.26460

  20. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing

    The Prostate

    Volume 75, Issue 5, April 1, 2015, Pages: 500–516, Chunjiao Song, Huan Chen, Tingzhang Wang, Weiguang Zhang, Guomei Ru and Juan Lang

    Article first published online : 16 JAN 2015, DOI: 10.1002/pros.22936